Neuroone Medical Technologies NMTC Estimates

NASDAQ NMTC
$1.66 -0.03 (-1.78%)
At close: Sep 9, 2026 · 4:00 PM EDT
Analyst Estimates

NEUROONE MEDICAL TECHNOLOGIES Corp Revenue Estimates

Periods 25
Next Period Q4 24
Consensus 1.71 M

Analysts expect NEUROONE MEDICAL TECHNOLOGIES Corp to report revenue of 1.71 M for Q4 24, against a range of 1.65 M to 1.76 M. The most recent reported quarter, Q3 26, came in at 1.97 M, a 5.4% beat against the 1.87 M consensus.

Metric Q4 24Q1 25Q2 25Q3 25Q4 25Q1 26Q2 26Q3 26Q4 26Q1 27Q2 27Q3 27Q4 27Q1 28Q2 28Q3 28Q4 28Q1 29Q2 29Q3 29Q4 29Q1 30Q2 30Q3 30Q4 30
Reported (Actual) -6.30 M1.39 M1.70 M2.72 M2.89 M2.39 M1.97 M-------
High Estimate 1.76 M2.06 M1.42 M1.79 M2.66 M2.65 M2.52 M2.00 M3.03 M3.62 M3.15 M3.28 M4.01 M5.50 M4.08 M
Low Estimate 1.65 M1.93 M1.30 M1.64 M2.49 M2.39 M2.33 M1.74 M2.69 M3.26 M2.59 M2.94 M3.77 M5.18 M3.61 M
Consensus Estimate 1.71 M2.00 M1.36 M1.71 M2.57 M2.52 M2.42 M1.87 M2.86 M3.44 M2.87 M3.11 M3.89 M5.34 M3.84 M
Analyst Estimates

NEUROONE MEDICAL TECHNOLOGIES Corp Earnings Per Share (EPS) Estimates

Periods 25
Next Period Q4 26
Consensus -0.21

Analysts expect NEUROONE MEDICAL TECHNOLOGIES Corp to report earnings per share of -0.21 for Q4 26, against a range of -0.22 to -0.20. The most recent reported quarter, Q3 26, came in at -0.23, a 4.5% miss against the -0.22 consensus.

Metric Q4 24Q1 25Q2 25Q3 25Q4 25Q1 26Q2 26Q3 26Q4 26Q1 27Q2 27Q3 27Q4 27Q1 28Q2 28Q3 28Q4 28Q1 29Q2 29Q3 29Q4 29Q1 30Q2 30Q3 30Q4 30
Reported (Actual) -0.660.36-0.42-0.18-0.30-0.17-0.25-0.23--------
High Estimate -0.54-0.52-0.54-0.29-0.21-0.21-0.23-0.20-0.20-0.15-0.17-0.18-0.17-0.02-0.16-0.09
Low Estimate -0.58-0.62-0.58-0.35-0.25-0.25-0.25-0.24-0.22-0.17-0.19-0.20-0.19-0.02-0.18-0.09
Consensus Estimate -0.56-0.57-0.56-0.32-0.23-0.23-0.24-0.22-0.21-0.16-0.18-0.19-0.18-0.02-0.17-0.09